inositol 1,4,5-trisphosphate receptor type 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| cell morphogenesis |
|
|
| response to hypoxia |
|
|
| response to hypoxia |
|
|
| monoatomic ion transport |
|
|
| ion transport |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| nuclear envelope |
|
|
| nuclear inner membrane |
|
|
| nucleolus |
|
|
| cytoplasm |
|
|
| endoplasmic reticulum |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| ion channel activity |
|
|
| monoatomic ion channel activity |
|
|
| inositol 1,4,5-trisphosphate-gated calcium channel activity |
|
|
| inositol 1,4,5-trisphosphate-gated calcium channel activity |
|
|
| inositol 1,4,5-trisphosphate-gated calcium channel activity |
|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050965 | spinocerebellar ataxia 15 | |
| DOID:0050978 | spinocerebellar ataxia 29 | |
| DOID:0111578 | Gillespie syndrome |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026